Review January 2011: Seroba Kernel heads up €3.75m funding round

Venture capital fund Seroba Kernel Life Sciences joined forces with Israeli venture capitalist Triventures to lead a €3.75 million funding round in the US-owned Apica Cardiovascular. Apica, a develope

Professor Terry Smith, head of research, NUI Galway; Dr Daniel O'Mahony, partner, Seroba Kernel Life Sciences; and James Greene, chief executive, Apica Cardiovascular.
Professor Terry Smith, head of research, NUI Galway; Dr Daniel O'Mahony, partner, Seroba Kernel Life Sciences; and James Greene, chief executive, Apica Cardiovascular.

Venture capital fund Seroba Kernel Life Sciences joined forces with Israeli venture capitalist Triventures to lead a €3.75 million funding round in the US-owned Apica Cardiovascular.

Apica, a developer of heart surgery systems, relocated from its base in Atlanta, Georgia, to the Innovation Centre in NUI Galway. Seroba Kernel Life Sciences partner ...